Main > A1. CORP. INDEX. A-Am No. 2 > Allakos Inc./P C2 > 2025. 01.27. CSU>AK006 Did NOT>
demonstrate therapeutic activity in CSU
– Allakos will discontinue further development of AK006, reduce workforce by 75% and explore strategic alternatives –
https://investor.allakos.com/news-releases/news-release-details/allakos-announces-topline-results-its-phase-1-trial-ak006
2025. 01.27. CSU>AK006 Did NOT>'s products
This section has no products